# 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

> **NCT07346235** · PHASE3 · NOT_YET_RECRUITING · sponsor: **American Hospital 2 Kosovo** · enrollment: 440 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** Follicle-stimulating hormone (FSH)
- **DRUG:** Follicle-stimulating hormone (FSH)

## Key facts

- **NCT ID:** NCT07346235
- **Lead sponsor:** American Hospital 2 Kosovo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-15
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346235, "150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07346235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*